Trial Outcomes & Findings for Behavioral Memory Modulation in Nicotine Addiction (NCT NCT03744559)

NCT ID: NCT03744559

Last Updated: 2025-04-30

Results Overview

At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a Craving Questionnaire survey at multiple timepoints during each visit (baseline, and after each cue exposure). The craving questionnaire is the average of four statements about craving for cigarettes (e.g., "I have an urge for a cigarette"), and the participants rate how they agree with the statements at that moment on a scale of 1 to 5 (1 = strongly disagree and 5 = strongly agree). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

191 participants

Primary outcome timeframe

up to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24

Results posted on

2025-04-30

Participant Flow

Participant milestones

Participant milestones
Measure
R-E (Retrieval Extinction)
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Overall Study
STARTED
81
82
Overall Study
COMPLETED
48
51
Overall Study
NOT COMPLETED
33
31

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Behavioral Memory Modulation in Nicotine Addiction

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
R-E (Retrieval Extinction)
n=81 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
n=82 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Total
n=163 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
79 Participants
n=5 Participants
78 Participants
n=7 Participants
157 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants
Age, Continuous
47.9 years
STANDARD_DEVIATION 11.5 • n=5 Participants
48.5 years
STANDARD_DEVIATION 11.0 • n=7 Participants
48.2 years
STANDARD_DEVIATION 11.2 • n=5 Participants
Sex: Female, Male
Female
38 Participants
n=5 Participants
41 Participants
n=7 Participants
79 Participants
n=5 Participants
Sex: Female, Male
Male
43 Participants
n=5 Participants
41 Participants
n=7 Participants
84 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
19 Participants
n=5 Participants
14 Participants
n=7 Participants
33 Participants
n=5 Participants
Race (NIH/OMB)
White
61 Participants
n=5 Participants
67 Participants
n=7 Participants
128 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
81 participants
n=5 Participants
82 participants
n=7 Participants
163 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24

Population: Participant included are those randomized to study treatment and return for at least 1 study visit. Mean response to the 4 CQ items and standard deviations to the novel cues are listed.

At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a Craving Questionnaire survey at multiple timepoints during each visit (baseline, and after each cue exposure). The craving questionnaire is the average of four statements about craving for cigarettes (e.g., "I have an urge for a cigarette"), and the participants rate how they agree with the statements at that moment on a scale of 1 to 5 (1 = strongly disagree and 5 = strongly agree). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Outcome measures

Outcome measures
Measure
R-E (Retrieval Extinction)
n=81 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
n=79 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Mean Craving Questionnaire Score, Response to the Novel Cue
Study Baseline
3.43 score on a scale, average of 4 responses
Standard Deviation 0.99
3.73 score on a scale, average of 4 responses
Standard Deviation 0.96
Mean Craving Questionnaire Score, Response to the Novel Cue
24 Hours
2.55 score on a scale, average of 4 responses
Standard Deviation 1.16
2.88 score on a scale, average of 4 responses
Standard Deviation 1.07
Mean Craving Questionnaire Score, Response to the Novel Cue
2 Weeks
2.40 score on a scale, average of 4 responses
Standard Deviation 0.95
2.59 score on a scale, average of 4 responses
Standard Deviation 1.14
Mean Craving Questionnaire Score, Response to the Novel Cue
6 Weeks
2.33 score on a scale, average of 4 responses
Standard Deviation 1.04
2.42 score on a scale, average of 4 responses
Standard Deviation 1.05
Mean Craving Questionnaire Score, Response to the Novel Cue
8 Weeks
2.39 score on a scale, average of 4 responses
Standard Deviation 0.95
2.25 score on a scale, average of 4 responses
Standard Deviation 1.06
Mean Craving Questionnaire Score, Response to the Novel Cue
24 Weeks
1.96 score on a scale, average of 4 responses
Standard Deviation 1.03
1.97 score on a scale, average of 4 responses
Standard Deviation 0.99
Mean Craving Questionnaire Score, Response to the Novel Cue
4 Weeks
2.49 score on a scale, average of 4 responses
Standard Deviation 0.99
2.60 score on a scale, average of 4 responses
Standard Deviation 1.09
Mean Craving Questionnaire Score, Response to the Novel Cue
12 Weeks
2.21 score on a scale, average of 4 responses
Standard Deviation 1.08
2.31 score on a scale, average of 4 responses
Standard Deviation 1.12

PRIMARY outcome

Timeframe: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26

Population: study population includes all participants that returned for a follow up visit at 2-weeks post intervention or later.

Cigarettes Smoked per Day were recorded daily and summarized at follow-up visits

Outcome measures

Outcome measures
Measure
R-E (Retrieval Extinction)
n=75 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
n=73 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Mean Cigarettes Smoked Per Day
Study Baseline
9.4 Average Cigarettes Smoked Per Day
Standard Deviation 7.7
10.1 Average Cigarettes Smoked Per Day
Standard Deviation 7.7
Mean Cigarettes Smoked Per Day
2 weeks
7.2 Average Cigarettes Smoked Per Day
Standard Deviation 9
6.7 Average Cigarettes Smoked Per Day
Standard Deviation 6.7
Mean Cigarettes Smoked Per Day
4 Weeks
7.5 Average Cigarettes Smoked Per Day
Standard Deviation 6.6
8.2 Average Cigarettes Smoked Per Day
Standard Deviation 8.5
Mean Cigarettes Smoked Per Day
6 weeks
8.1 Average Cigarettes Smoked Per Day
Standard Deviation 8.4
7.9 Average Cigarettes Smoked Per Day
Standard Deviation 7.1
Mean Cigarettes Smoked Per Day
8 weeks
8.3 Average Cigarettes Smoked Per Day
Standard Deviation 8.4
7.7 Average Cigarettes Smoked Per Day
Standard Deviation 6.5
Mean Cigarettes Smoked Per Day
12 Weeks
8.1 Average Cigarettes Smoked Per Day
Standard Deviation 8.2
7.7 Average Cigarettes Smoked Per Day
Standard Deviation 6.3
Mean Cigarettes Smoked Per Day
16 weeks
8.5 Average Cigarettes Smoked Per Day
Standard Deviation 10.8
7.8 Average Cigarettes Smoked Per Day
Standard Deviation 7
Mean Cigarettes Smoked Per Day
26 Weeks
8.5 Average Cigarettes Smoked Per Day
Standard Deviation 11.9
7.1 Average Cigarettes Smoked Per Day
Standard Deviation 6.5
Mean Cigarettes Smoked Per Day
21 Weeks
9 Average Cigarettes Smoked Per Day
Standard Deviation 11.6
7.5 Average Cigarettes Smoked Per Day
Standard Deviation 6.6

SECONDARY outcome

Timeframe: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26

Population: study population includes all participants that returned for a follow up visit at 2-weeks post intervention or later.

Cigarettes Smoking days were recorded daily and summarized at follow-up visits. The percentage of days since last follow up visit where smoking is recorded is reported

Outcome measures

Outcome measures
Measure
R-E (Retrieval Extinction)
n=81 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
n=82 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Percentage of Smoking Days
Study Baseline
98.5 percentage of days reported smoking
Standard Deviation 5.3
98.1 percentage of days reported smoking
Standard Deviation 10.5
Percentage of Smoking Days
2 weeks
72.5 percentage of days reported smoking
Standard Deviation 37.8
70.2 percentage of days reported smoking
Standard Deviation 40
Percentage of Smoking Days
4 Weeks
76.1 percentage of days reported smoking
Standard Deviation 39.2
74.7 percentage of days reported smoking
Standard Deviation 39.4
Percentage of Smoking Days
6 weeks
77.1 percentage of days reported smoking
Standard Deviation 38.9
73.8 percentage of days reported smoking
Standard Deviation 40
Percentage of Smoking Days
8 weeks
77 percentage of days reported smoking
Standard Deviation 37.5
75.1 percentage of days reported smoking
Standard Deviation 39
Percentage of Smoking Days
12 Weeks
73.2 percentage of days reported smoking
Standard Deviation 41.7
74 percentage of days reported smoking
Standard Deviation 37.4
Percentage of Smoking Days
16 weeks
68.2 percentage of days reported smoking
Standard Deviation 43.8
70.7 percentage of days reported smoking
Standard Deviation 42.5
Percentage of Smoking Days
21 Weeks
64.8 percentage of days reported smoking
Standard Deviation 46.4
67.9 percentage of days reported smoking
Standard Deviation 41.6
Percentage of Smoking Days
26 Weeks
62.4 percentage of days reported smoking
Standard Deviation 44.4
66.2 percentage of days reported smoking
Standard Deviation 42.7

SECONDARY outcome

Timeframe: up to 24 weeks, Baseline, 24 Hours, Weeks 2, 4, 6, 8, 12, and 24

Population: Participant included are those randomized to study treatment and return for at least 1 study visit. Mean mood-Craving response and standard deviations to the novel cues are listed.

At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a mood craving during each visit. The mood craving form is a single item question ranging from 0 (no craving) to 100 (greatest craving possible). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Outcome measures

Outcome measures
Measure
R-E (Retrieval Extinction)
n=80 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
NR-E (No R-E)
n=81 Participants
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
Mean Mood-Craving Response to the Novel Cue
Study Baseline
62.1 score on a scale, 0-100
Standard Deviation 29.2
69.5 score on a scale, 0-100
Standard Deviation 24.2
Mean Mood-Craving Response to the Novel Cue
24 Hours
38.1 score on a scale, 0-100
Standard Deviation 29.7
46.5 score on a scale, 0-100
Standard Deviation 29.1
Mean Mood-Craving Response to the Novel Cue
4 Weeks
33.1 score on a scale, 0-100
Standard Deviation 29.6
33.4 score on a scale, 0-100
Standard Deviation 31.2
Mean Mood-Craving Response to the Novel Cue
6 Weeks
29.7 score on a scale, 0-100
Standard Deviation 27.4
31.1 score on a scale, 0-100
Standard Deviation 29.3
Mean Mood-Craving Response to the Novel Cue
8 Weeks
31.8 score on a scale, 0-100
Standard Deviation 25.1
30.5 score on a scale, 0-100
Standard Deviation 29.6
Mean Mood-Craving Response to the Novel Cue
12 Weeks
29.6 score on a scale, 0-100
Standard Deviation 27.6
31.3 score on a scale, 0-100
Standard Deviation 29.4
Mean Mood-Craving Response to the Novel Cue
24 Weeks
23.1 score on a scale, 0-100
Standard Deviation 27.1
23.3 score on a scale, 0-100
Standard Deviation 29.6
Mean Mood-Craving Response to the Novel Cue
2 Weeks
32.3 score on a scale, 0-100
Standard Deviation 26.5
33.5 score on a scale, 0-100
Standard Deviation 31.6

Adverse Events

R-E (Retrieval Extinction)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

NR-E (No R-E)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Michael Saladin

Medical University of South Carolina

Phone: (843) 792-5306

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place